
Storyful Ltd
verifiedGLP-1’s Next Act? Addiction, PCOS, and More
This article explores how GLP-1 drugs are entering a “next act” as online communities push their use far beyond diabetes and obesity, with off-label interest rising over 7,000% year-on-year. Using Storyful’s analysis of 30k social posts (Feb 2024–... Read more